Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Clene Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$71.7 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.1 - $4.12 $507,647 - $995,956	-241,737 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.42 - $4.42 $20,565 - $37,561	-8,498 Reduced 3.4%	241,737 $952,000
Q4 2021 Feb 07, 2022	BUY	$3.95 - $7.53 $988,428 - $1.88 Million	250,235 New	250,235 $1.11 Million

Others Institutions Holding CLNN

# of Institutions

Shares Held

7.44M

Call Options Held

48.1K

Put Options Held

160K

Vanguard Group Inc Valley Forge, PA

2.62M
Shares

$864,501
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

947K
Shares

$312,355
0.0% of portfolio
Lunt Capital Management, Inc. Holladay, UT

513K
Shares

$169,244
0.11% of portfolio
Scoggin Management LP New York, NY

500K
Shares

$165,000
0.08% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

474K
Shares

$156,462
0.0% of portfolio

View Full List

About Clene Inc.

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

More about CLNN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account